Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZNTL Zentalis Pharmaceuticals, LLC

休市中 07-11 16:00:00 EDT

1.33

-0.04

-2.92%

盘后1.30

-0.03-2.22%

18:34 EDT

最高1.37	最低1.29	成交量62.35万
今开1.37	昨收1.37	日振幅6.20%
总市值9,570万	流通市值6,623万	总股本7,195万
成交额82.25万	换手率1.25%	流通股本4,979万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZNTL","market":"US","secType":"STK","nameCN":"Zentalis Pharmaceuticals, LLC","latestPrice":1.33,"timestamp":1752264000000,"preClose":1.37,"halted":0,"volume":623546,"hourTrading":{"tag":"盘后","latestPrice":1.3005,"preClose":1.33,"latestTime":"18:34 EDT","volume":686,"amount":910.3812,"timestamp":1752273279165},"delay":0,"floatShares":49794681,"shares":71951934,"eps":-3.145366,"marketStatus":"休市中","change":-0.04,"latestTime":"07-11 16:00:00 EDT","open":1.37,"high":1.37,"low":1.285,"amount":822535.9902144,"amplitude":0.062044,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.145366,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1585886400000,"exchange":"NASDAQ","adjPreClose":1.37,"preHourTrading":{"tag":"盘前","latestPrice":1.36,"preClose":1.37,"latestTime":"09:27 EDT","volume":248,"amount":335.62308720000004,"timestamp":1752240438935},"postHourTrading":{"tag":"盘后","latestPrice":1.3005,"preClose":1.33,"latestTime":"18:34 EDT","volume":686,"amount":910.3812,"timestamp":1752273279165},"volumeRatio":0.465235,"impliedVol":0.2181,"impliedVolPercentile":0.024},"requestUrl":"/m/hq/s/ZNTL/wiki","defaultTab":"wiki","newsList":[{"id":"2550952724","title":"Zentalis Pharmaceuticals, Inc.盘中异动 急速跳水5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952724?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:39","pubTimestamp":1752244755,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时39分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.11%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223916a4451a22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223916a4451a22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2549817526","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549817526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549817526?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:31","pubTimestamp":1751985078,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时31分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.04%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223118a43e4913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223118a43e4913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4539","BK4139","ZNTL"],"gpt_icon":0},{"id":"2549558902","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558902?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:42","pubTimestamp":1751895762,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时42分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.16%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214242a69b1e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214242a69b1e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2548830518","title":"Zentalis Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.16%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548830518?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:51","pubTimestamp":1751385086,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时51分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.16%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701235126a728c3c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701235126a728c3c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2546196729","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.56%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546196729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546196729?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053811,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.56%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035011a721736e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035011a721736e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2546575822","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速跳水5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546575822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546575822?lang=zh_cn&edition=full","pubTime":"2025-06-27 00:51","pubTimestamp":1750956716,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日00时51分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.34%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062700515697902b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062700515697902b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2544798481","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.43%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544798481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544798481?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:33","pubTimestamp":1750429987,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日22时33分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.43%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202233079788180a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202233079788180a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2544999129","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544999129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544999129?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:34","pubTimestamp":1750174487,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时34分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.30%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506172334489783965f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506172334489783965f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2543605830","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543605830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543605830?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:38","pubTimestamp":1750081128,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时38分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.97%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213848a4ac361b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213848a4ac361b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2543633085","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543633085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543633085?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:15","pubTimestamp":1749824100,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时15分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.14%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613221500951b311a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613221500951b311a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2542538393","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.21%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542538393?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:08","pubTimestamp":1749650939,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时08分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.21%。截至发稿，该股报1.55美元/股，成交量18.1802万股，换手率0.25%，振幅5.21%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112208599517f2e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112208599517f2e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2542348605","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.37%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542348605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542348605?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:07","pubTimestamp":1749564475,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时07分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.37%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061022075597797f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061022075597797f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2541861692","title":"Zentalis Pharmaceuticals, Inc.盘中异动 急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541861692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541861692?lang=zh_cn&edition=full","pubTime":"2025-06-06 23:07","pubTimestamp":1749222475,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日23时07分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.20%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606230756a6fd5dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606230756a6fd5dfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2541757320","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541757320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541757320?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:40","pubTimestamp":1749130805,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时40分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.33%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214005a6fbd960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214005a6fbd960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2540229792","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.37%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540229792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540229792?lang=zh_cn&edition=full","pubTime":"2025-06-03 00:38","pubTimestamp":1748882306,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日00时38分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.37%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.12%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603003826a6f74f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603003826a6f74f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2537705923","title":"Zentalis Pharmaceuticals, Inc.2025财年第一财季实现净利润-48.28百万美元，同比减少579.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537705923","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537705923?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929640,"startTime":"0","endTime":"0","summary":"5月23日，Zentalis Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第一财季净利润为-48.28百万美元，同比减少579.44%；其中营业收入为0.00美元，每股基本收益为-0.67美元。从资产负债表来看，Zentalis Pharmaceuticals, Inc.总负债88.64百万美元，其中短期债务0.00美元，资产负债比为0.05，流动比率为0.07。机构评级：截至2025年5月23日，当前有8家机构对Zentalis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.28美元，其中最低目标价为2.20美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000203a48876ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000203a48876ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL"],"gpt_icon":0},{"id":"2537534269","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅下跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537534269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537534269?lang=zh_cn&edition=full","pubTime":"2025-05-22 02:04","pubTimestamp":1747850656,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日02时04分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.47%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202041694fe3469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202041694fe3469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2535097877","title":"Zentalis Pharmaceuticals, Inc.盘中异动 临近收盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535097877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535097877?lang=zh_cn&edition=full","pubTime":"2025-05-16 03:49","pubTimestamp":1747338575,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日03时49分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.03%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.11%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051603493594f83102&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051603493594f83102&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2534276615","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534276615?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056751,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.28%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221323197574458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221323197574458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2534156072","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534156072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534156072?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:20","pubTimestamp":1746721216,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时20分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.69%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.17%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900201794f0b199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900201794f0b199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentalis.com","stockEarnings":[{"period":"1week","weight":0.0556},{"period":"1month","weight":-0.1014},{"period":"3month","weight":0.0813},{"period":"6month","weight":-0.5164},{"period":"1year","weight":-0.6658},{"period":"ytd","weight":-0.5611}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zentalis Pharmaceuticals, Inc.于2014年12月23日在特拉华州以Zeno Pharmaceuticals，Inc.的身份注册成立。Zentalis Pharmaceuticals，Inc.是一家临床阶段制药公司，致力于发现和开发针对癌症基本生物途径的临床分化的新型小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.210798},{"month":2,"riseRate":0.6,"avgChangeRate":0.043937},{"month":3,"riseRate":0.4,"avgChangeRate":-0.061863},{"month":4,"riseRate":0.4,"avgChangeRate":-0.036484},{"month":5,"riseRate":0.5,"avgChangeRate":0.074443},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.096016},{"month":7,"riseRate":0.5,"avgChangeRate":-0.032956},{"month":8,"riseRate":0.2,"avgChangeRate":0.016639},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089748},{"month":10,"riseRate":0.6,"avgChangeRate":0.026783},{"month":11,"riseRate":0.6,"avgChangeRate":0.039766},{"month":12,"riseRate":0.6,"avgChangeRate":0.028044}],"exchange":"NASDAQ","name":"Zentalis Pharmaceuticals, LLC","nameEN":"Zentalis Pharmaceuticals, LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zentalis Pharmaceuticals, LLC,ZNTL,Zentalis Pharmaceuticals, LLC股票,Zentalis Pharmaceuticals, LLC股票老虎,Zentalis Pharmaceuticals, LLC股票老虎国际,Zentalis Pharmaceuticals, LLC行情,Zentalis Pharmaceuticals, LLC股票行情,Zentalis Pharmaceuticals, LLC股价,Zentalis Pharmaceuticals, LLC股市,Zentalis Pharmaceuticals, LLC股票价格,Zentalis Pharmaceuticals, LLC股票交易,Zentalis Pharmaceuticals, LLC股票购买,Zentalis Pharmaceuticals, LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}